The BIO International Convention 2026, widely recognized as the largest and most influential event in the global biotechnology industry, will be held from June 22 to 25, 2026, in San Diego, California, USA.
The convention is expected to attract more than 20,000 industry leaders, researchers, business development professionals, and investors from over 70 countries and regions worldwide. Under the theme “Driven by Purpose", BIO 2026 will highlight the biotechnology industry's commitment to improving human health, advancing scientific innovation, and addressing global health and sustainability challenges.
This year's convention is expected to feature more than 130 conference sessions spanning 18 key focus areas, including artificial intelligence and digital health, cell and gene therapies, next-generation therapeutics, rare disease drug development, biomanufacturing, global market opportunities, intellectual property, and regulatory policy.
As a wholly-owned subsidiary of Asymchem Laboratories, Inc. (SZSE: 002821; HKEX: 6821), Asymchem Clinical (Clin-Nov) will join Asymchem at the convention to showcase its End-to-End Service platform spanning the entire drug development lifecycle, from research and development through commercialization. The team will engage with global pharmaceutical and biotechnology partners to discuss new opportunities and strategies for the worldwide development of innovative medicines.
Conference Information
Conference: BIO International Convention 2026
Date: June 22–25, 2026
Location: San Diego Convention Center, San Diego, California, USA
About Us
Asymchem Clinical (Clin-Nov) is a wholly-owned subsidiary of Asymchem Laboratories, Inc. (SZSE: 002821; HKEX: 6821), dedicated to providing global partners with high-quality, end-to-end drug development services.
Its service offerings span the entire clinical development continuum, from IND to NDA, delivering comprehensive clinical development solutions that include pre-IND consulting, regulatory affairs, medical strategy development, medical writing and monitoring, clinical monitoring, clinical operations and project management, data management and statistical programming, pharmacovigilance, third-party auditing, clinical supply chain management, and digital intelligence-enabled services.
Leveraging an integrated service model and extensive industry expertise, Asymchem Clinical empowers the efficient advancement of innovative therapies from early-stage development through regulatory approval and commercialization.